1. Home
  2. SEPN vs EVGO Comparison

SEPN vs EVGO Comparison

Compare SEPN & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • EVGO
  • Stock Information
  • Founded
  • SEPN 2022
  • EVGO 2010
  • Country
  • SEPN United States
  • EVGO United States
  • Employees
  • SEPN 75
  • EVGO N/A
  • Industry
  • SEPN
  • EVGO Other Specialty Stores
  • Sector
  • SEPN
  • EVGO Consumer Discretionary
  • Exchange
  • SEPN NYSE
  • EVGO Nasdaq
  • Market Cap
  • SEPN 553.0M
  • EVGO 462.9M
  • IPO Year
  • SEPN 2024
  • EVGO N/A
  • Fundamental
  • Price
  • SEPN $12.21
  • EVGO $3.30
  • Analyst Decision
  • SEPN Strong Buy
  • EVGO Buy
  • Analyst Count
  • SEPN 5
  • EVGO 9
  • Target Price
  • SEPN $26.75
  • EVGO $6.13
  • AVG Volume (30 Days)
  • SEPN 222.3K
  • EVGO 3.8M
  • Earning Date
  • SEPN 08-15-2025
  • EVGO 08-05-2025
  • Dividend Yield
  • SEPN N/A
  • EVGO N/A
  • EPS Growth
  • SEPN N/A
  • EVGO N/A
  • EPS
  • SEPN N/A
  • EVGO N/A
  • Revenue
  • SEPN $977,000.00
  • EVGO $276,954,000.00
  • Revenue This Year
  • SEPN $3,429.67
  • EVGO $40.85
  • Revenue Next Year
  • SEPN N/A
  • EVGO $32.54
  • P/E Ratio
  • SEPN N/A
  • EVGO N/A
  • Revenue Growth
  • SEPN 108.76
  • EVGO 45.15
  • 52 Week Low
  • SEPN $4.17
  • EVGO $2.20
  • 52 Week High
  • SEPN $28.99
  • EVGO $9.07
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • EVGO 37.63
  • Support Level
  • SEPN N/A
  • EVGO $3.82
  • Resistance Level
  • SEPN N/A
  • EVGO $3.87
  • Average True Range (ATR)
  • SEPN 0.00
  • EVGO 0.21
  • MACD
  • SEPN 0.00
  • EVGO -0.03
  • Stochastic Oscillator
  • SEPN 0.00
  • EVGO 8.63

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About EVGO EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

Share on Social Networks: